Novartis Retreats, But Not Entirely, on 340B Contract Pharmacy (Update 2)
Update 2, Friday Oct. 30, 4:00 p.m. EDT—Hospital group 340B Health said Novartis’ action was inexcusable.
…Category: Breaking
Health Centers Sue HHS Over Drug Company Denials of 340B Pricing
This is a developing story. Check the online version for possible updates.
The National Association of
…Breaking News
BREAKING: Major Developments in 340B Hospital Lawsuit and in 340B Contract Pharmacy Dispute
U.S. Appeals Court Won’t Rehear Lawsuit Over Medicare Payment Cuts for Hospitals’ 340B-Purchased Drugs
The full U.S. Court of Appeals for the District of Columbia Circuit late this afternoon denied a motion to reconsider a three-judge panel’s
…
HIV/AIDS Clinics Sue HHS Over Drug Manufacturers’ Denials of 340B Pricing
(UPDATE Saturday Oct. 10, 2020, 9:20 a.m. EDT—The U.S. Health and Human Services Department (HHS) said
…
Congressional GOP Committee Leaders Seek 340B Reform Ideas by Oct. 30
The Republican chairman of the U.S. Senate Health, Education, Labor, and Pensions (HELP) Committee and the
…A message from 340B Report Publisher and CEO Ted Slafsky: We are pleased to have a sponsored content piece today from Powers Law, based in Washington, D.C. We will have more information about 340B Report sponsorship packages for 2021 in
…Novartis Says It’s Weighing Whether to Start Cutting Off 340B Contract Pharmacy Discounts on Oct. 1. Sanofi Says it Will.
(Update 1, Friday Sept. 25, 1:00 p.m. EDT—Merck is “considering any next steps in our effort to ensure compliance with
…HHS Top Lawyer Tells Lilly, Don’t Assume We Endorse Your 340B Policy
The top lawyer at the U.S. Health and Human Services (HHS) department told drug manufacturer Eli Lilly and Co. in a letter dated Sept. 21 and made
…Rule Implementing 340B Executive Order on Insulin Might be Imminent
The Trump administration signaled today it might publish an interim final rule imminently to implement an executive order requiring community health centers to pass along all 340B savings on insulin
…Breaking News
BREAKING: 22 U.S. Senate Democrats Want Answers from PhRMA About its Members’ 340B Actions
22 U.S. Senate Democrats Want Answers from PhRMA About its Members’ 340B Actions
Twenty-two Democratic U.S. senators asked Pharmaceutical Research and Manufacturers of America (PhRMA) today to inform them by no later than Sept. 29 “regarding steps being taken by
…